Stay abreast of the latest scientific developments and learn how the biopharma industry and medical community are finding new ways to improve decision-making and patient care. Here, we share our perspectives on a variety of topics in biopharma, healthcare, medical communications, and more.
As Senior Vice President, Ms. Khan will champion innovative digital solutions and new offerings for Vaniam Group clients
Mr Tulk will spearhead innovative digital solutions, advanced analytics, and new offerings for Vaniam Group’s clients.
Ms Gott’s extensive background in hematology and solid tumors, as well as her biopharma experience, will drive strategic initiatives, enhance client solutions, and foster long-term client relationships.
Eighteen early-career clinical investigators to receive year-long mentorship through professional development program led by international thought leaders
Leou Ismael Banla, MD, PhD, receives annual Conquer Cancer-Vaniam Group LLC Young Investigator Award, dedicated to Black, African, or African American cancer researchers and Erica Pimenta, MD, PhD, receives annual Conquer Cancer-Women Leaders in Oncology “Women Who Conquer Cancer” Young Investigator Award
Vaniam Group CSS (Clinical Strategy and Solutions) poster focuses on “Improving Clinical Trial Performance Using Adult-Learning Methods”
Ms. Scholz brings 25 years of leadership experience driving the success of oncology brands across several top pharmaceutical companies
Early-career clinical investigators continue year-long mentorship and professional development program led by international thought leaders
Awards presented at the 5th Annual LEAD conference for women in oncology and hematology
Mr. Neave brings 15+ years of CFO experience within mid- to large-sized medical communications and pharma services agencies
This marks the fourth consecutive year that Vaniam Group has qualified for this prestigious honor.
